Newron Pharmaceuticals S.p.A. (ETR:NP5)
7.53
+0.06 (0.80%)
Jul 9, 2025, 5:35 PM CET
Newron Pharmaceuticals Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Updated Sep 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.